InflaRx N.V. (IFRX)
NASDAQ: IFRX · Real-Time Price · USD
1.790
+0.120 (7.19%)
May 13, 2025, 4:00 PM - Market closed
InflaRx Employees
InflaRx had 74 employees as of December 31, 2024. The number of employees increased by 12 or 18.97% compared to the previous year.
Employees
74
Change (1Y)
12
Growth (1Y)
18.97%
Revenue / Employee
$1,895
Profits / Employee
-$653,200
Market Cap
121.01M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
IFRX News
- 6 days ago - InflaRx Reports First Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 13 days ago - InflaRx to Report First Quarter 2025 Results on May 7, 2025 - GlobeNewsWire
- 7 weeks ago - InflaRx Reports Full Year 2024 Results and Highlights Key Achievements and Expected Milestones - GlobeNewsWire
- 2 months ago - InflaRx Showcases Vilobelimab's Role in Immuno-Dermatology at the 2025 AAD Annual Meeting - GlobeNewsWire
- 2 months ago - InflaRx to Showcase Vilobelimab's Role in Immuno-Dermatology at the 2025 AAD Annual Meeting - GlobeNewsWire
- 2 months ago - InflaRx to Report Full Year 2024 Results on March 20 and Announces Participation in March Investor Conferences - GlobeNewsWire
- 3 months ago - InflaRx Announces Closing of $30 Million Public Offering of Ordinary Shares and Pre-Funded Warrants - GlobeNewsWire
- 3 months ago - InflaRx Announces Pricing of $30 Million Public Offering of Ordinary Shares and Pre-Funded Warrants - GlobeNewsWire